Alliance in the News RSS

The NCI Alliance for Nanotechnology in Cancer is conducting cutting-edge research using nanotechnology to transform the diagnosis, prevention, treatment, and clinical outcomes for cancer patients. Read news stories and announcements below about the Alliance's multidisciplinary work.

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

2013

• Pfizer Makes Nanomedicines Deal With Bind Therapeutics
  Bloomberg — April 3, 2013
• Langer startup BINDs nanomedicine and drug targeting in $180M-plus Amgen deal
  FierceDrugDelivery — January 8, 2013
• Beckman Researchers Lead Nanopore Effort at Illinois
  Beckman Institute News — January 8, 2013